Tilray Italia
Rome, ItalyFounded 2019
About Tilray Italia
Italian subsidiary of Canadian LP Tilray, supplying GMP-grade medical cannabis products to Italian pharmacies through the national health system.
Key Facts
- 1One of the first international LPs authorised to supply medical cannabis to Italy's SSN health system
- 2Products dispensed through hospital and community pharmacies with a medical prescription
Latest News
Tilray's Multi-Sector Bet Tests Cannabis Investor Patience
2d ago
TLRY's expansion beyond cannabis into alcohol and wellness creates revenue diversification but raises questions about capital allocation efficiency and core competency focus.
Tilray's Beverage Expansion Tests Cannabis Diversification Playbook
2d ago
TLRY's alcohol portfolio now generates more revenue than cannabis operations, marking a strategic pivot that challenges traditional sector valuations.
Frequently Asked Questions
How do patients access Tilray products in Italy?
Patients need a prescription from an authorised physician; products are dispensed at licensed pharmacies.
Is Tilray Italia publicly traded?
The parent company Tilray Brands trades on NASDAQ under TLRY; the Italian subsidiary is not separately listed.
More Cannabis Companies in Rome
TLRY Stock
View live price, chart & analysis
Cannabis Laws
Products
- Dried medical cannabis
- Cannabis oil extracts
Specialties
GMP medical cannabis importItalian pharmacy distribution
Company Details
- Type
- Medical & Pharma
- Location
- Rome, Italy
- Founded
- 2019
- Publicly Traded
- Yes
- Ticker
- NASDAQ:TLRY
Browse all Medical & Pharma
View more companies in this category
Related Companies
More in Italy
Enecta
Bologna \u2014 CBD & Hemp
Stabilimento Chimico Farmaceutico Militare (SCFM)
Florence \u2014 Producer & Grower
Emmac/Curaleaf International
Milan \u2014 Medical & Pharma
SCFM Military Production
Florence \u2014 Producer & Grower